Comparing Two Techniques of Haemostasis After Cervical Conization
NCT ID: NCT03293628
Last Updated: 2017-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
100 participants
INTERVENTIONAL
2014-10-01
2016-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conization With Vaginal Packing
Experimental Arm. Haemostasis at the end of the procedure using vaginal packing and Monsel's solution.
Vaginal Packing
This study will evaluate the role of vaginal packing after cervical conization as haemostasis technique
Conization Without Vaginal Packing
Haemostasis at the end of the procedure using only Monsel's solution.
Vaginal Packing
This study will evaluate the role of vaginal packing after cervical conization as haemostasis technique
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vaginal Packing
This study will evaluate the role of vaginal packing after cervical conization as haemostasis technique
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
68 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barretos Cancer Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ricardo dos Reis
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ricardo D Reis, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital do Câncer de Barretos
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital do Câncer de Barretos
Barretos, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
826/2014
Identifier Type: -
Identifier Source: org_study_id